Toll Free: 1-888-928-9744

Electrophysiology Devices - Medical Devices Pipeline Assessment, 2015

Published: Dec 31, 2015 | Pages: 226 | Publisher: GlobalData | Industry: Medical Devices | Report Format: Electronic (PDF)

Electrophysiology Devices - Medical Devices Pipeline Assessment, 2015

Summary

GlobalData's Medical Devices sector report, "Electrophysiology Devices - Medical Devices Pipeline Assessment, 2015" provides an overview of Electrophysiology Devices currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Electrophysiology Devices pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

- Extensive coverage of the Electrophysiology Devices under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Electrophysiology Devices and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry

Reasons to Buy

The report enables you to - 
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Electrophysiology Devices under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product's current stage of development, territory and estimated launch date
 Table of Contents

1 Table of Contents 2
1.1 List of Tables 5
1.2 List of Figures 11

2 Introduction 12
2.1 Electrophysiology Devices Overview 12

3 Products under Development 14
3.1 Electrophysiology Devices - Pipeline Products by Stage of Development 14
3.2 Electrophysiology Devices - Pipeline Products by Segment 15
3.3 Electrophysiology Devices - Pipeline Products by Territory 16
3.4 Electrophysiology Devices - Pipeline Products by Regulatory Path 18
3.5 Electrophysiology Devices - Pipeline Products by Estimated Approval Date 19
3.6 Electrophysiology Devices - Ongoing Clinical Trials 20

4 Electrophysiology Devices - Pipeline Products under Development by Companies 21
4.1 Electrophysiology Devices Companies - Pipeline Products by Stage of Development 21
4.2 Electrophysiology Devices - Pipeline Products by Stage of Development 24

5 Electrophysiology Devices Companies and Product Overview 27
5.1 AblaCor Medical Corporation Company Overview 27
5.1.1 AblaCor Medical Corporation Pipeline Products & Ongoing Clinical Trials Overview 27
5.2 Acutus Medical, Inc. Company Overview 28
5.2.1 Acutus Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 28
5.3 Advanced Cardiac Therapeutics, Inc. Company Overview 30
5.3.1 Advanced Cardiac Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 30
5.4 AFfix Medical Ltd. Company Overview 31
5.4.1 AFfix Medical Ltd. Pipeline Products & Ongoing Clinical Trials Overview 31
5.5 Apama Medical, Inc. Company Overview 34
5.5.1 Apama Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 34
5.6 AtriCure, Inc. Company Overview 35
5.6.1 AtriCure, Inc. Pipeline Products & Ongoing Clinical Trials Overview 35
5.7 Baylor College of Medicine Company Overview 41
5.7.1 Baylor College of Medicine Pipeline Products & Ongoing Clinical Trials Overview 41
5.8 Biosense Webster, Inc. Company Overview 43
5.8.1 Biosense Webster, Inc. Pipeline Products & Ongoing Clinical Trials Overview 43
5.9 BioSig Technologies, Inc. Company Overview 47
5.9.1 BioSig Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 47
5.10 BioTex, Inc. Company Overview 48
5.10.1 BioTex, Inc. Pipeline Products & Ongoing Clinical Trials Overview 48
5.11 Boston Scientific Corporation Company Overview 50
5.11.1 Boston Scientific Corporation Pipeline Products & Ongoing Clinical Trials Overview 50
5.12 C. R. Bard, Inc. Company Overview 65
5.12.1 C. R. Bard, Inc. Pipeline Products & Ongoing Clinical Trials Overview 65
5.13 Cardima, Inc. (Inactive) Company Overview 69
5.13.1 Cardima, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 69
5.14 CardioFocus, Inc. Company Overview 72
5.14.1 CardioFocus, Inc. Pipeline Products & Ongoing Clinical Trials Overview 72
5.15 CardioNova Ltd. Company Overview 76
5.15.1 CardioNova Ltd. Pipeline Products & Ongoing Clinical Trials Overview 76
5.16 CathEffects LLC Company Overview 77
5.16.1 CathEffects LLC Pipeline Products & Ongoing Clinical Trials Overview 77
5.17 CathRx Ltd Company Overview 78
5.17.1 CathRx Ltd Pipeline Products & Ongoing Clinical Trials Overview 78
5.18 Cordis Corporation Company Overview 82
5.18.1 Cordis Corporation Pipeline Products & Ongoing Clinical Trials Overview 82
5.19 CoRepair, Inc Company Overview 84
5.19.1 CoRepair, Inc Pipeline Products & Ongoing Clinical Trials Overview 84
5.20 CyberHeart Incorporated Company Overview 85
5.20.1 CyberHeart Incorporated Pipeline Products & Ongoing Clinical Trials Overview 85
5.21 Epicardial Technologies Inc Company Overview 87
5.21.1 Epicardial Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 87
5.22 FocusStart Orthosensors Company Overview 88
5.22.1 FocusStart Orthosensors Pipeline Products & Ongoing Clinical Trials Overview 88
5.23 Fundacion para la Investigacion Biomedica del Hospital Gregorio Maranon Company Overview 89
5.23.1 Fundacion para la Investigacion Biomedica del Hospital Gregorio Maranon Pipeline Products & Ongoing Clinical Trials Overview 89
5.24 Hansen Medical, Inc. Company Overview 90
5.24.1 Hansen Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 90
5.25 Imricor Medical Systems, Inc. Company Overview 97
5.25.1 Imricor Medical Systems, Inc. Pipeline Products & Ongoing Clinical Trials Overview 97
5.26 Interventional Imaging, Inc. Company Overview 102
5.26.1 Interventional Imaging, Inc. Pipeline Products & Ongoing Clinical Trials Overview 102
5.27 Iowa Approach Inc. Company Overview 103
5.27.1 Iowa Approach Inc. Pipeline Products & Ongoing Clinical Trials Overview 103
5.28 Maestro Heart SA Company Overview 106
5.28.1 Maestro Heart SA Pipeline Products & Ongoing Clinical Trials Overview 106
5.29 Mayo Clinic. Company Overview 107
5.29.1 Mayo Clinic. Pipeline Products & Ongoing Clinical Trials Overview 107
5.30 MC10, Inc. Company Overview 108
5.30.1 MC10, Inc. Pipeline Products & Ongoing Clinical Trials Overview 108
5.31 Medicalgorithmics S.A. Company Overview 110
5.31.1 Medicalgorithmics S.A. Pipeline Products & Ongoing Clinical Trials Overview 110
5.32 Medispec LTD Company Overview 111
5.32.1 Medispec LTD Pipeline Products & Ongoing Clinical Trials Overview 111
5.33 Medlumics S.L. Company Overview 113
5.33.1 Medlumics S.L. Pipeline Products & Ongoing Clinical Trials Overview 113
5.34 Medtronic plc Company Overview 115
5.34.1 Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview 115
5.35 MedWaves Incorporated Company Overview 120
5.35.1 MedWaves Incorporated Pipeline Products & Ongoing Clinical Trials Overview 120
5.36 MicroPort Scientific Corporation Company Overview 122
5.36.1 MicroPort Scientific Corporation Pipeline Products & Ongoing Clinical Trials Overview 122
5.37 MRI Interventions, Inc Company Overview 125
5.37.1 MRI Interventions, Inc Pipeline Products & Ongoing Clinical Trials Overview 125
5.38 nContact, Inc. Company Overview 127
5.38.1 nContact, Inc. Pipeline Products & Ongoing Clinical Trials Overview 127
5.39 North Carolina State University Company Overview 131
5.39.1 North Carolina State University Pipeline Products & Ongoing Clinical Trials Overview 131
5.40 Northwestern University Company Overview 132
5.40.1 Northwestern University Pipeline Products & Ongoing Clinical Trials Overview 132
5.41 Philips Healthcare Company Overview 134
5.41.1 Philips Healthcare Pipeline Products & Ongoing Clinical Trials Overview 134
5.42 SCR, Inc. Company Overview 136
5.42.1 SCR, Inc. Pipeline Products & Ongoing Clinical Trials Overview 136
5.43 St. Jude Medical, Inc. Company Overview 137
5.43.1 St. Jude Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 137
5.44 Stereotaxis, Inc. Company Overview 144
5.44.1 Stereotaxis, Inc. Pipeline Products & Ongoing Clinical Trials Overview 144
5.45 Strategic Polymer Sciences, Inc Company Overview 147
5.45.1 Strategic Polymer Sciences, Inc Pipeline Products & Ongoing Clinical Trials Overview 147
5.46 The Cleveland Clinic Foundation Company Overview 148
5.46.1 The Cleveland Clinic Foundation Pipeline Products & Ongoing Clinical Trials Overview 148
5.47 University of Rochester Company Overview 150
5.47.1 University of Rochester Pipeline Products & Ongoing Clinical Trials Overview 150
5.48 University of Texas Medical Branch at Galveston Company Overview 152
5.48.1 University of Texas Medical Branch at Galveston Pipeline Products & Ongoing Clinical Trials Overview 152
5.49 Vimecon GmbH Company Overview 154
5.49.1 Vimecon GmbH Pipeline Products & Ongoing Clinical Trials Overview 154
5.50 Vivonics, Inc. Company Overview 156
5.50.1 Vivonics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 156
5.51 Voyage Medical Company Overview 159
5.51.1 Voyage Medical Pipeline Products & Ongoing Clinical Trials Overview 159

6 Electrophysiology Devices- Recent Developments 161

7 Appendix 223
7.1 Methodology 223
7.2 About GlobalData 225
7.3 Contact Us 226
7.4 Disclaimer 226
List of Tables
Table 1: Electrophysiology Devices - Pipeline Products by Stage of Development 14 Table 2: Electrophysiology Devices - Pipeline Products by Segment 15 Table 3: Electrophysiology Devices - Pipeline Products by Territory 17 Table 4: Electrophysiology Devices - Pipeline Products by Regulatory Path 18 Table 5: Electrophysiology Devices - Pipeline Products by Estimated Approval Date 19 Table 6: Electrophysiology Devices - Ongoing Clinical Trials 20 Table 7: Electrophysiology Devices Companies - Pipeline Products by Stage of Development 21 Table 8: Electrophysiology Devices - Pipeline Products by Stage of Development 24 Table 9: AblaCor Medical Corporation Pipeline Products & Ongoing Clinical Trials Overview 27 Table 10: AutoBlator - Product Status 27 Table 11: AutoBlator - Product Description 27 Table 12: Acutus Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 28 Table 13: AcQMap System - Product Status 29 Table 14: AcQMap System - Product Description 29 Table 15: Advanced Cardiac Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 30 Table 16: Next Generation TempaSure Ablation Catheter - Product Status 30 Table 17: Next Generation TempaSure Ablation Catheter - Product Description 30 Table 18: AFfix Medical Ltd. Pipeline Products & Ongoing Clinical Trials Overview 31 Table 19: Catheter Ablation Device - Product Status 31 Table 20: Catheter Ablation Device - Product Description 31 Table 21: AFfix Medical Ltd. - Ongoing Clinical Trials Overview 32 Table 22: Catheter Ablation Device - Transcutaneous Monitoring to Avoid Hypercapnea During Complex Catheter Ablations: a Joint Quality Initiative Pilot From Cardiac Electrophysiology and Anesthesiology 33 Table 23: Apama Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 34 Table 24: Apama Ablation Catheter - Product Status 34 Table 25: Apama Ablation Catheter - Product Description 34 Table 26: AtriCure, Inc. Pipeline Products & Ongoing Clinical Trials Overview 35 Table 27: AtriCure MIS System - Standalone - Product Status 36 Table 28: AtriCure MIS System - Standalone - Product Description 36 Table 29: Dual Epicardial And Endocardial Device - Product Status 37 Table 30: Dual Epicardial And Endocardial Device - Product Description 37 Table 31: Next Generation RF Generator - Product Status 38 Table 32: Next Generation RF Generator - Product Description 38 Table 33: AtriCure, Inc. - Ongoing Clinical Trials Overview 39 Table 34: Dual Epicardial And Endocardial Device - Feasibility Trial of a Staged Epicardial & Endocardial Approach for Treatment of Patients with Persistent or Long Standing Persistent Atrial Fibrillation with Radiofrequency Ablation 40 Table 35: Baylor College of Medicine Pipeline Products & Ongoing Clinical Trials Overview 41 Table 36: Electrical-Anatomical Imaging Catheter - Product Status 42 Table 37: Electrical-Anatomical Imaging Catheter - Product Description 42 Table 38: Biosense Webster, Inc. Pipeline Products & Ongoing Clinical Trials Overview 43 Table 39: nMARQ Pulmonary Vein Isolation System - Product Status 44 Table 40: nMARQ Pulmonary Vein Isolation System - Product Description 44 Table 41: Biosense Webster, Inc. - Ongoing Clinical Trials Overview 45 Table 42: nMARQ Pulmonary Vein Isolation System - Efficacy, Safety and Efficiency of the nMARQ Pulmonary Vein Isolation System in the Treatment of Paroxysmal Atrial Fibrillation - A Pilot Study 46 Table 43: nMARQ Pulmonary Vein Isolation System - Microembolic Signals During CPVI (Circumferntial Pulmonary Vein Isolation) Assessed by TCD (Trans-cranial Doppler) 46 Table 44: nMARQ Pulmonary Vein Isolation System - Remarkable nMARQ Pulmonary Vein Isolation System for the Treatment of Paroxysmal Atrial Fibrillation 46 Table 45: BioSig Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 47 Table 46: PURE EP System - Product Status 47 Table 47: PURE EP System - Product Description 47 Table 48: BioTex, Inc. Pipeline Products & Ongoing Clinical Trials Overview 48 Table 49: Cooled Tip Catheter - Product Status 48 Table 50: Cooled Tip Catheter - Product Description 48 Table 51: Water-cooled Catheter - Product Status 49 Table 52: Water-cooled Catheter - Product Description 49 Table 53: Boston Scientific Corporation Pipeline Products & Ongoing Clinical Trials Overview 50 Table 54: Blazer Open Irrigated Ablation Catheter - Product Status 51 Table 55: Blazer Open Irrigated Ablation Catheter - Product Description 51 Table 56: Cryo Balloon Catheter - Product Status 52 Table 57: Cryo Balloon Catheter - Product Description 52 Table 58: IntellaNav MiFi OI Catheter - Product Status 53 Table 59: IntellaNav MiFi OI Catheter - Product Description 53 Table 60: IntellaNav MiFi XP Catheter - Product Status 54 Table 61: IntellaNav MiFi XP Catheter - Product Description 54 Table 62: IntellaNav OI Catheter - Product Status 55 Table 63: IntellaNav OI Catheter - Product Description 55 Table 64: IntellaNav XP Catheter - Product Status 56 Table 65: IntellaNav XP Catheter - Product Description 56 Table 66: IntellaTip MiFi 4.5 Open-Irrigated Catheter - Product Status 57 Table 67: IntellaTip MiFi 4.5 Open-Irrigated Catheter - Product Description 57 Table 68: LabSystem PRO NextGen - Product Status 58 Table 69: LabSystem PRO NextGen - Product Description 58 Table 70: Lesion Assessment Device - Product Status 59 Table 71: Lesion Assessment Device - Product Description 59 Table 72: Next Generation Blazer Catheter - Product Status 60 Table 73: Next Generation Blazer Catheter - Product Description 60 Table 74: Next Generation IntellaTip Catheter - Product Status 61 Table 75: Next Generation IntellaTip Catheter - Product Description 61 Table 76: OI System - Product Status 62 Table 77: OI System - Product Description 62 Table 78: Boston Scientific Corporation - Ongoing Clinical Trials Overview 63 Table 79: Blazer Open Irrigated Ablation Catheter - Clinical Evaluation of the Blazer Open-Irrigated Ablation Catheter for the Treatment of Paroxysmal Atrial Fibrillation 64 Table 80: C. R. Bard, Inc. Pipeline Products & Ongoing Clinical Trials Overview 65 Table 81: BARD HD MESH Ablation System - Product Status 66 Table 82: BARD HD MESH Ablation System - Product Description 66 Table 83: BARD HD MESH Mapper Catheter - Product Status 67 Table 84: BARD HD MESH Mapper Catheter - Product Description 67 Table 85: ENCOMPASS - Product Status 68 Table 86: ENCOMPASS - Product Description 68 Table 87: Cardima, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 69 Table 88: CADENCE EPL - Product Status 69 Table 89: CADENCE EPL - Product Description 69 Table 90: EP Ablation System - Product Status 70 Table 91: EP Ablation System - Product Description 70 Table 92: New Energy Management Device - Product Status 71 Table 93: New Energy Management Device - Product Description 71 Table 94: CardioFocus, Inc. Pipeline Products & Ongoing Clinical Trials Overview 72 Table 95: HeartLight Endoscopic Ablation System - Product Status 73 Table 96: HeartLight Endoscopic Ablation System - Product Description 73 Table 97: CardioFocus, Inc. - Ongoing Clinical Trials Overview 74 Table 98: HeartLight Endoscopic Ablation System - Catheter Ablation of Drug-refractory Persistent Atrial Fibrillation with the HeartLight Laser Balloon in Comparison with Irrigated Radio frequency Current Ablation 75 Table 99: HeartLight Endoscopic Ablation System - Endoscopically Guided Laser Ablation of Persistent Atrial Fibrillation (Eagle AF) 75 Table 100: CardioNova Ltd. Pipeline Products & Ongoing Clinical Trials Overview 76 Table 101: Catheter To Treat Atrial Fibrillation - Product Status 76 Table 102: Catheter To Treat Atrial Fibrillation - Product Description 76 Table 103: CathEffects LLC Pipeline Products & Ongoing Clinical Trials Overview 77 Table 104: Desai VectorCathRF1 Mapping And Ablation Catheter - Product Status 77 Table 105: Desai VectorCathRF1 Mapping And Ablation Catheter - Product Description 77 Table 106: CathRx Ltd Pipeline Products & Ongoing Clinical Trials Overview 78 Table 107: CathRx 4mm Therapeutic Catheter - Product Status 79 Table 108: CathRx 4mm Therapeutic Catheter - Product Description 79 Table 109: CathRx 8mm Therapeutic Catheter - Product Status 80 Table 110: CathRx 8mm Therapeutic Catheter - Product Description 80 Table 111: Non-Irrigated Ablation Catheter - Product Status 81 Table 112: Non-Irrigated Ablation Catheter - Product Description 81 Table 113: Cordis Corporation Pipeline Products & Ongoing Clinical Trials Overview 82 Table 114: EP Contact Force Sensing Catheter Enabled By CARTO 3 - Product Status 82 Table 115: EP Contact Force Sensing Catheter Enabled By CARTO 3 - Product Description 82 Table 116: EP Lesion Assessment Device - Product Status 83 Table 117: EP Lesion Assessment Device - Product Description 83


List of Figures
Figure 1: Electrophysiology Devices - Pipeline Products by Stage of Development 14 Figure 2: Electrophysiology Devices - Pipeline Products by Segment 15 Figure 3: Electrophysiology Devices - Pipeline Products by Territory 16 Figure 4: Electrophysiology Devices - Pipeline Products by Regulatory Path 18 Figure 5: Electrophysiology Devices - Pipeline Products by Estimated Approval Date 19 Figure 6: Electrophysiology Devices - Ongoing Clinical Trials 20

To request a free sample copy of this report, please complete the form below.

This website is secure and your personal details are safe. Privacy policy

Global automotive coatings market size is likely to be valued at USD 27.7 billion by 2022; as per a new research report by Radiant Insights, Inc. Vehicle aesthetics, UV radiation and temperature variation protection and enhance durability are certain

Read More...

Global heat transfer fluids market size is likely to be valued at USD 3.7 billion by 2020; as per a new research report by Radiant Insights, Inc. Increasing demand for for heat recovery management in industries such as metal processing, pharmaceutica

Read More...

Global CoQ10 market size was 687.2 tons in 2014 and is expected to reach 1,168 tons by 2020, growing at a CAGR of 9.2% from 2014 to 2020, according to a new study by Radiant Insights, Inc. Increasing scope in personal care applications is expected to

Read More...

Global embedded system market is projected to be valued at USD 214.39 billion by 2020, as per a new research report by Radiant Insights, Inc. Rising demand from end-use industries such as automotive and healthcare coupled with emergence of Internet o

Read More...

Global fumaric acid market size is anticipated to be valued at USD 764.8 million by 2020, as per a new research report by Radiant Insights, Inc. Growing processed food demand coupled with RTD (ready-to-drink) beverages consumption is expected to driv

Read More...
Choose License Type
Single User - US $4000
Multi User - US $8000
Why Choose Us

24/5 Research support

Get your queries resolved from an industry expert. Request for a free product review before report purchase.

Phone: 1-415-349-0054

Toll Free: 1-888-928-9744

Email: [email protected]

Custom research service

Speak to the report author to design an exclusive study to serve your research needs.

Quality assurance

A testimonial for service excellence represented in the form of BBB "A" Accreditation.

Information security

Your personal and confidential information is safe and secure.

verify